PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2026-01-09

Date Title Company
09-Jan-2026 Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial Businesswire
09-Jan-2026 Latin America Industrial Cleaning Products Market Report 2025-2034: 6.5% CAGR Projected - ResearchAndMarkets.com Businesswire
09-Jan-2026 Vida Ventures Congratulates Aktis Oncology on Its Entry into the Public Markets Businesswire
09-Jan-2026 Future Trajectory of the $4.7 Billion Protein Expression Market, 2025-2030 - ResearchAndMarkets.com Businesswire
09-Jan-2026 Number of Shares and Voting Rights of ADOCIA as of December 31st, 2025 Businesswire
09-Jan-2026 Enthorin Therapeutics Announces Initiation of Phase II Clinical Trial of MRM-3379 (Formerly ENT-3379) for Fragile X Syndrome by Licensing Partner Mirum Pharmaceuticals Businesswire
09-Jan-2026 Diorasis Therapeutics Appoints Richard A. Kresch, MD, to Board of Directors Businesswire
09-Jan-2026 PharmaJet’s Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data Businesswire
09-Jan-2026 KeifeRx Announces Research Collaboration and Option Agreement with Amneal Pharmaceuticals to Advance KFRX06, a Brain-Penetrant LRRK2 Program for Parkinson’s Disease Businesswire
09-Jan-2026 Scott+Scott Attorneys at Law LLP Reminds Investors of Its Investigation Into Corcept Therapeutics Incorporated (NASDAQ: CORT) Businesswire
09-Jan-2026 Enhanced Genomics Appoints Dr Katerina Leftheris to Its Board of Directors Businesswire
09-Jan-2026 City of Hope Appoints Veteran Life Sciences Leader Vanessa Almendro Navarro as Chief Commercialization Officer Businesswire
09-Jan-2026 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Jan-2026 Avant Brands Adopts Shareholder Rights Plan ACCESS Newswire
09-Jan-2026 MEDIPOST Inc. Announces $140 Million in Funding to Accelerate Late-Stage Clinical Development Businesswire
09-Jan-2026 Revvity Collaborates with Lilly to Expand Access to AI Drug Discovery Models Businesswire
09-Jan-2026 Orca Bio Announces $250M in Aggregate Financing in Preparation for Potential Commercialization Businesswire
09-Jan-2026 AirNexis Therapeutics Launches with $200M Series A to Advance Phase 2 Dual PDE3/4 Inhibitor AN01 for Chronic Obstructive Pulmonary Disease (COPD) Businesswire
09-Jan-2026 Mammoth Biosciences to Present at 44th Annual J.P. Morgan Healthcare Conference Businesswire
09-Jan-2026 Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C) Businesswire